Biologics and oral small‐molecule inhibitors for treatment of pediatric atopic dermatitis: Opportunities and challenges
ABSTRACT Atopic dermatitis (AD) is a complex disease characterized by recurrent eczematous lesions and refractory pruritus that drastically impairs quality of life. Due to the chronic and relapsing course, patients are easily trapped in the debilitating condition. Classical therapies show limitation...
Saved in:
Main Authors: | Anqi Zhao (Author), Chaolan Pan (Author), Ming Li (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
by: Robin C. Yi, et al.
Published: (2024) -
Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges
by: Isha Bansal, et al.
Published: (2023) -
Biologicals for pediatric patients with atopic dermatitis: practical challenges and knowledge gaps
by: Lisa P. van der Rijst, et al.
Published: (2023) -
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective
by: Alba Guglielmo, et al.
Published: (2023) -
Transformation of peptides to small molecules in medicinal chemistry: Challenges and opportunities
by: Zeyu Han, et al.
Published: (2024)